Source comparison
AOD-9604 MOTS-C Fat Metabolism Research: Protocol Comparison
Single-peptide lipolysis model 500 mcg–1 mg Not used Once daily (AM fasted) Free fatty acids, glycerol, body composition Effective for isolated lipolysis studies but doesn't capture oxidative fate of mobilized fat. Limited insight into net metabolic impact Sin
This comparison does not assign a generated winner or score.
- Single-peptide lipolysis model
- 500 mcg–1 mg
- Not used
- Once daily (AM fasted)
- Free fatty acids, glycerol, body composition
- Effective for isolated lipolysis studies but doesn't capture oxidative fate of mobilized fat. Limited insight into net metabolic impact
- Single-peptide insulin sensitivity model
- 10–15 mg
- Once daily (PM)
- Glucose tolerance, insulin sensitivity, AMPK phosphorylation
- Strong for muscle metabolism research but doesn't address adipose tissue dysfunction. Misses the fat mobilization component
- Dual-peptide sequential protocol
- 500 mcg
- 10 mg
- AOD-9604 AM, MOTS-C PM
- Lipolysis markers + insulin sensitivity + mitochondrial respiration
- Captures full metabolic cycle from fat release to oxidation. Most comprehensive model for metabolic syndrome research
- High-dose dual protocol
- 1 mg
- 15 mg
- Both administered AM fasted
- All above + inflammatory markers (IL-6, TNF-alpha)
- Used in obesity research where adipose inflammation is a primary endpoint. Higher doses increase risk of receptor desensitization over long protocols